PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34882521-8	2022	Circ_0073748 was upregulated and miR-132-3p was downregulated in AP patients" plasma and human pancreatic ductal HPDE6-C7 cells with caerulein induction.	Ceruletide	133-142	microRNA 1323	Homo sapiens	33-43	
34882521-9	2022	Interfering circ_0073748 and reinforcing miR-132-3p improved cell viability, EdU incorporation, and superoxide dismutase (SOD) activity of caerulein-treated HPDE6-C7 cells but suppressed malonaldehyde (MDA), IL-6 and TNF-alpha levels and apoptosis rate.	Ceruletide	139-148	microRNA 1323	Homo sapiens	41-51	
34882521-10	2022	Moreover, TRAF3 downregulation was allied with circ_0073748 silencing and miR-132-3p overexpression in caerulein-induced HPDE6-C7 cells.	Ceruletide	103-112	microRNA 1323	Homo sapiens	74-84	
34882521-12	2022	Notably, circ_0073748 blockage could suppress expressions of phosphorylated P65 (p-P65) and p-IkappaB in caerulein-induced HPDE6-C7 cells by promoting miR-132-3p and inhibiting TRAF3.	Ceruletide	105-114	microRNA 1323	Homo sapiens	151-161	
34882521-13	2022	Silencing circ_0073748 and upregulating miR-132-3p could alleviate caerulein-induced HPDE6-C7 injury and inactivate canonical NF-kappaB signal by inhibiting TRAF3.	Ceruletide	67-76	microRNA 1323	Homo sapiens	40-50	
34882521-14	2022	Circ_0073748/miR-132-3p/TRAF3 ceRNA pathway might be one underlying mechanism and therapeutic target of caerulein-induced AP.	Ceruletide	104-113	microRNA 1323	Homo sapiens	13-23